errata - 01:53, 2008-Jun-22 |
| About Promacta(R) (Eltrombopag) Eltrombopag, a novel oral thrombopoeitin (TPO) receptor agonist, if approved, would be the first oral short-term treatment of previously treated patients with chronic ITP to increase platelet counts and reduce or prevent bleeding. bellhop colonizer pores exquisite ****** canadian And it wasn't the first time in his Tar Heels career. |
 |